HK2 and liver cancer: The expression of type II hexokinase (HKII), a key enzyme in glycolysis, is up-regulated in liver cancer by DNA hypomethylation, which could accelerate glycolytic flux in cancer cells (Goel et al., 2003; Johnson et al., 2015).